Dear Dr. Renukaprasad A R, A single treatment for the multifaceted dry eye disease (DED) condition is a novel therapy! The prevalence of DED varies by country, ranging from 5% to 34%. DED directly affects the interpalpebral ocular surface and tear film, thus resulting in vision disruption. A single solution for the multifactorial disease is the need of the hour, especially for treating advanced DED. Propylene glycol (PG) and hydroxypropyl guar (HPG) with nano-sized lipid excipients optimize the lipid surface and maintain a healthy ocular surface. Additionally, it offers the surface epithelium a shield of defense. Watch this video to learn how this formulation applies to all DED subtypes!
Highlights: - DED classification
- PG-HPG formulation and mode of action
- Impact of PG-HPG formulation on the ocular surface
|
No comments:
Post a Comment